"Talk about free advertising," exclaimed Forbes. "Cadillac's first 'customer' for its redesigned, 2006 DTS will be President George W. Bush, who will ride in a black limousine version of the new car during his inaugural parade on January 20." Deville marketing manager Keith Spondike said that Bush's use of the DTS will reinforce Cadillac's image of "appealing to and transporting high-profile people."
"The United Nations is looking for a well-connected Washington figure to head its information office," reports the Financial Times, "as part of a wide-ranging image makeover to improve relations with Congress." The "makeover" began earlier this month, when Kofi Annan named Mark Malloch Brown, former PR consultant to Corazon Aquino and the
Nicolle Devenish, the new White House communications director, was "once fired for being too nice to reporters," writes the New York Times' Elisabeth Bumiller.
"President Bush's political allies are raising millions of dollars for an election-style campaign to promote private Social Security accounts, as Democrats and Republicans prepare for what they predict will be the most expensive and extensive public policy debate since the 1993 fight over the Clinton administration's failed health care plan," reports Jim VandeHei.
The "first permanent communications war room for Democrats on Capitol Hill," the Senate Democratic Communications Center, has been launched.
The 2004 presidential race was the most expensive in history. While Republicans did outspend Democrats -- $1.14 billion to $1.08 billion -- the difference wasn't that much. "Despite their fundraising success, Democrats simply did not spend their money as effectively as Bush," the Washington Post's Thomas Edsall and James Grimaldi report.
Representative Billy Tauzin, "a principal author of the new Medicare drug law, will become president of the Pharmaceutical Research and Manufacturers of America, the chief lobby for brand-name drug companies." The Medicare law is generous to industry, forbidding price controls, regulations, or even negotiations with drug manufacturers "to secure lower prices for Medicare beneficiari